Enhanced inflammatory response following coronary stent implantation in stable angina patients

Carlos V Serrano1, Elise S Santos, José A Mangione

  • 1Heart Institute (InCor), University of São Paulo, Medical School, Brazil. carlos.serrano@incor.usp.br

Insights

Patients with lipid-rich plaques experienced a greater inflammatory response after coronary stent implantation compared to those with calcified plaques. This finding highlights the importance of plaque morphology in predicting post-PCI inflammation.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Inflammation Research

Background:

  • Percutaneous coronary intervention (PCI) increases inflammatory activity.
  • The relationship between post-PCI inflammation and plaque morphology is not well understood.
  • Characterizing this inflammatory response based on plaque type is crucial for understanding outcomes.

Purpose of the Study:

  • To investigate the association between plaque morphology and the inflammatory response following coronary stent implantation (CSI).
  • To compare the inflammatory mediator levels in patients with different plaque types before and after CSI.

Main Methods:

  • Sixty-two stable angina patients undergoing elective CSI were included.
  • Intravascular ultrasound (IVUS) classified plaques as calcified (C), fibrocalcified (FC), fibrolipidic (FL), or lipidic (L).
  • Coronary sinus samples measured inflammatory mediators (IL-6, TNF, IFN, neopterin) at baseline and 15 minutes post-CSI.

Main Results:

  • Lipidic (L) and fibrolipidic (FL) plaques showed significantly higher increases in IL-6, TNF, IFN, and neopterin post-CSI compared to baseline.
  • Calcified (C) and fibrocalcified (FC) plaques exhibited a less pronounced inflammatory response.
  • Specific plaque types (B1, B2) also showed differential inflammatory changes, particularly for IL-6 and IFN.

Conclusions:

  • Stable angina patients with lipidic (L, FL) plaques demonstrate a more substantial inflammatory response after CSI than those with calcified (C, FC) plaques.
  • Plaque morphology is a significant determinant of the acute inflammatory reaction to coronary stent implantation.
  • These findings may inform risk stratification and treatment strategies post-PCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...